Genomines raised €38M in a Series A round in Sep 2025. The company is based in Paris, France. Investors in the round: AlphaTech Investment Group, DeepTech & Climate Fonds, Elemental Impact and 10 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
